Ernexa Therapeutics stock surges 30% on preclinical data

This is a summary. Read the complete story at Investing.com below.

Related Stories

stocksabout 3 hours ago

Buy the dip in this Canadian stock: RJ

Investing.com

stocksabout 4 hours ago

How sustainable is the AI investment boom after Thursday’s selloff?

Investing.com

stocksabout 4 hours ago

Golf-BC Partners seeks control of LIV Golf from Saudi wealth fund, FT reports

Investing.com